首页> 美国卫生研究院文献>PLoS Medicine >Prices Costs and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis

【2h】

Prices Costs and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis

机译：30个国家中丙型肝炎新药的价格成本和负担能力：经济分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

IntroductionNew hepatitis C virus (HCV) medicines have markedly improved treatment efficacy and regimen tolerability. However, their high prices have limited access, prompting wide debate about fair and affordable prices. This study systematically compared the price and affordability of sofosbuvir and ledipasvir/sofosbuvir across 30 countries to assess affordability to health systems and patients.

机译：简介新的丙型肝炎病毒（HCV）药物显着改善了治疗效果和方案耐受性。但是，它们的高价格限制了人们的访问，这引发了关于公平和可承受价格的广泛争论。这项研究系统地比较了30个国家中sofosbuvir和ledipasvir / sofosbuvir的价格和负担能力，以评估对卫生系统和患者的负担能力。

著录项

期刊名称 PLoS Medicine
作者
Swathi Iyengar; Kiu Tay-Teo; Sabine Vogler; Peter Beyer; Stefan Wiktor; Kees de Joncheere; Suzanne Hill;
展开▼
作者单位

展开▼
年(卷),期 2016(13),5
年度 2016
页码 e1002032
总页数 22
原文格式 PDF
正文语种
中图分类基础医学;
关键词

相似文献

外文文献
中文文献
专利

1. Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis [J] . Swathi Iyengar, Kiu Tay-Teo, Sabine Vogler, PLoS Medicine . 2016,第5期

机译：30个国家的丙型肝炎新药物的价格，成本和负担能力：经济分析
2. Availability, Price, and Affordability of Selected Essential Medicines for Chronic Diseases in 11 Countries of the Asia Pacific Region: A Secondary Analysis [J] . Wang Haipeng, Sun Qiang, Vitry Agnes, Theoretical and Experimental Plant Physiology . 2017,第4期

机译：亚太地区11个国家慢性疾病所选慢性疾病所选择的必要药物的可用性，价格和负担能力：二级分析
3. Effect of the Affordable Medicines Facility-malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data [J] . Sarah Tougher, the ACTwatch Group, Yazoume Ye, The Lancet . 2012,第9857期

机译：负担得起的药物设施-疟疾（AMFm）对七个国家基于质量保证的青蒿素类联合疗法的可获得性，价格和市场份额的影响：门店调查数据的前后分析
4. Economic costs of drought and rice farmers' coping mechanisms: A synthesis of cross-country comparative analysis [C] . S. PANDEY, H. BHANDARI, R. SHARAN, Workshop of the International Maize and Wheat Improvement Center . 2004

机译：干旱和水稻农民应对机制的经济成本：跨国对比分析的合成
5. Economic evaluation of vaccination programs: Cost-effectiveness, externalities, and affordability of hepatitis B vaccination. [D] . Kim, Sun-Young. 2006

机译：疫苗接种计划的经济评估：乙肝疫苗接种的成本效益，外部性和负担能力。
6. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists Price Availability and Affordability [O] . Muhammad Jami Husain, Biplab Kumar Datta, Deliana Kostova, 2020

机译：进入发展中国家的心血管疾病和高血压药物：对基本药物清单价格可用性和负担能力分析
7. Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis. [O] . Swathi Iyengar, Kiu Tay-Teo, Sabine Vogler, 2016

机译：30个国家丙型肝炎新药的价格，成本和支付能力：经济分析。
8. Social Cost-Benefit Analysis: A Guide for Country and Project Economists to the Derivation and Application of Economic and Social Accounting Prices [R] . Bruce, C. 1976

机译：社会成本 - 效益分析：国家和项目经济学家对经济和社会会计价格的推导和应用的指南

Prices Costs and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis

摘要

著录项

相似文献

相关主题

期刊订阅